-
Melinda Yushak, MD, MPH; Emory University Winship Cancer Institute; #DDHO2022
7:03
-
Michael Lowe, MD; Emory University Winship Cancer Institute; #DDHO2022
10:47
-
Michael Atkins, MD; Georgetown; #DDHO2022
18:10
-
Melinda Yushak, MD, MPH; Emory University Winship Cancer Institute; #DDHO2022
15:09
-
Adoptive cell therapy in melanoma_Melinda Yushak, MD, MPH; #DDHO2021
2:12
-
DEBATE-Adjuvant vs. neoadjuvant therapy in Stage III melanoma_Michael Lowe, MD, MA and Ragi Kudchadkar, MD; #DDHO2021
4:11
ABOUT
Bio Ascend is an independent medical education company committed to supporting healthcare providers in their efforts to translate innovative science into clinical practice.
The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components, as well as extensive experience in planning, executing, and assessing meaningful education for clinicians.
CONNECT
© Copyright 2021 Bio Ascend, a Vaniam Group company